Dantrolene
Dantrolene and Derivatives
- Drug class
- Dantrolene and Derivatives
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 16
Overview
Dantrolene is an active pharmaceutical ingredient in the Dantrolene and Derivatives group (M03CA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 15 | March 6, 2026 |
| US United States | FDA | 1 | December 22, 2024 |
GBUnited Kingdom· MHRA
15 products
Uses
Dantrium capsules are indicated for the treatment of chronic, severe spasticity of skeletal muscle resulting from disorders such as stroke, spinal cord injury, cerebral palsy and multiple sclerosis in adults and children over the age of 5 years old weighing 25 kg or more.
How to take
USUnited States· FDA
1 product
Uses
INDICATIONS AND USAGE
, spinal cord injury, stroke, cerebral palsy, or multiple sclerosis). It is of particular benefit to the patient whose functional rehabilitation has been retarded by the sequelae of spasticity. Such patients must have presumably reversible spasticity where relief of spasticity will aid in restoring residual function.
Dantrolene sodium is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. If improvement occurs, it will ordinarily occur within the dosage titration (see DOSAGE AND ADMINISTRATION ), and will be manifested by a decrease in the severity of spasticity and the ability to resume a daily function not quite attainable without dantrolene sodium.
Occasionally, subtle but meaningful improvement in spasticity may occur with dantrolene sodium therapy. In such instances, information regarding improvement should be solicited from the patient and those who are in constant daily contact and attendance with him.
Drug interactions
Known interactions involving Dantrolene. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 277. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL200110033 · revised October 17, 2025
- [2]FDA DailyMed · 11689f56-15e0-43… · revised December 22, 2024 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.